🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
* To determine the utility of novel blood-based immune monitoring tools (Al...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2020-02-11
Trial ID
NCT04177095
Treatments Being Tested
The purpose of this study is to understand the effects of everolimus on tac...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2014-04
Trial ID
NCT02077556
Treatments Being Tested
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
The purpose of this study is to understand physician treatment decisions in...
Status
Completed
Location
Arkansas Children's Hospital
Start Date
2013-08
Trial ID
NCT01971684
Treatments Being Tested
This is an open label, single-center, randomized phase IV pilot study of st...
Status
Terminated
Location
Northwestern University/Northwestern Memorial Hospital
Start Date
2005-04
Trial ID
NCT00166712
Treatments Being Tested
The objectives of this study are to determine the efficacy and safety of BE...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2016-02
Trial ID
NCT02411084
Treatments Being Tested
The purpose of this study is to compare the effect of two anti-rejection th...
Status
Completed
Location
5042
Start Date
2011-03-08
Trial ID
NCT01363752
Treatments Being Tested
The purpose of this study is look at the safety of: * Taking a specific co...
Status
Terminated
Location
University of California, San Francisco
Start Date
2014-12-17
Trial ID
NCT02188719
The purpose of this study was to evaluate whether delayed (i.e. 28 ± 4 days...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-11
Trial ID
NCT01410448
Treatments Being Tested
The purpose of this study is to assess the efficacy of ruxolitinib against ...
Status
Completed
Location
Incyte Investigative Site
Start Date
2017-06-29
Trial ID
NCT03112603